ADmit THERAPEUTICS - test for an early AD detection. Alzheimer's disease. DETECTION IN CLINICAL PRACTICE. ADmit Therapeutics, S.L. is a company focused on the development and commercialization of a novel Alzheimer's disease (AD) early detection technology.